GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 45 filers reported holding GALERA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,087 | -94.4% | 69,029 | 0.0% | 0.00% | – |
| Q2 2023 | $215,370 | +187.5% | 69,029 | +135.9% | 0.00% | – |
| Q1 2023 | $74,921 | +71.8% | 29,266 | 0.0% | 0.00% | – |
| Q4 2022 | $43,606 | -14.5% | 29,266 | 0.0% | 0.00% | – |
| Q3 2022 | $51,000 | +112.5% | 29,266 | +61.0% | 0.00% | – |
| Q2 2022 | $24,000 | -44.2% | 18,175 | 0.0% | 0.00% | – |
| Q1 2022 | $43,000 | -48.2% | 18,175 | 0.0% | 0.00% | – |
| Q4 2021 | $83,000 | -43.5% | 18,175 | 0.0% | 0.00% | – |
| Q3 2021 | $147,000 | +1.4% | 18,175 | +22.8% | 0.00% | – |
| Q2 2021 | $145,000 | -82.7% | 14,795 | -84.4% | 0.00% | – |
| Q1 2021 | $838,000 | -17.0% | 94,945 | -3.9% | 0.00% | – |
| Q4 2020 | $1,010,000 | +7.4% | 98,763 | -5.0% | 0.00% | – |
| Q3 2020 | $940,000 | +26.3% | 103,945 | -0.2% | 0.00% | – |
| Q2 2020 | $744,000 | +134.7% | 104,185 | +211.8% | 0.00% | – |
| Q1 2020 | $317,000 | -27.0% | 33,411 | +1.3% | 0.00% | – |
| Q4 2019 | $434,000 | – | 32,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
| Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
| Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
| ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
| Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
| Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
| XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
| Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
| Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
| Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |